KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Cash (2017 - 2025)

Historic Change in Cash for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$46.0 million.

  • Guardant Health's Change in Cash rose 8674.87% to -$46.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 9950.35%. This contributed to the annual value of -$503.9 million for FY2024, which is 15081.3% down from last year.
  • Guardant Health's Change in Cash amounted to -$46.0 million in Q3 2025, which was up 8674.87% from -$68.4 million recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Change in Cash peaked at $676.3 million during Q4 2023, and registered a low of -$358.3 million during Q2 2022.
  • For the 5-year period, Guardant Health's Change in Cash averaged around -$7.6 million, with its median value being -$16.7 million (2022).
  • Its Change in Cash has fluctuated over the past 5 years, first plummeted by 61641.33% in 2022, then soared by 415859.34% in 2023.
  • Quarter analysis of 5 years shows Guardant Health's Change in Cash stood at -$340.4 million in 2021, then surged by 95.1% to -$16.7 million in 2022, then surged by 4158.59% to $676.3 million in 2023, then crashed by 108.67% to -$58.6 million in 2024, then increased by 21.58% to -$46.0 million in 2025.
  • Its Change in Cash was -$46.0 million in Q3 2025, compared to -$68.4 million in Q2 2025 and $174.1 million in Q1 2025.